Planet Adds Stoke Space Launch Deal, Operational Flexibility Not Enough to Shift Thesis

What happened

Planet Labs announced a multi-launch agreement with Stoke Space for its Nova rocket, adding another launch provider alongside existing ties to Isar Aerospace. This aligns with Planet's push to expand sovereign and commercial satellite capacity, but it comes against a backdrop of declining firm contracted value, with RPO and backlog both falling in recent quarters. While securing diverse launch options reduces schedule risk, it does not address the near-term revenue softness or widening capital intensity flagged in the last earnings cycle. The agreement likely increases future capex commitments without immediate revenue recognition, adding to the execution burden management must navigate. Overall, the development is a modest positive for operational resilience but fails to resolve the core valuation and balance-sheet concerns that keep the stock at a WAIT rating.

Implication

Investors should view this launch agreement as a move to de-risk future constellation deployment rather than a catalyst for near-term value creation. The added launch optionality supports Planet's ability to execute on sovereign programs, but the company still faces a Q3 guide-down and declining backlog, which are the primary drivers of valuation. Moreover, each new launch commitment adds to an already elevated capex plan for FY2027, raising the bar for free cash flow generation. Until Planet shows that firm contracted value is replenishing without further dilution, the stock is likely to remain range-bound. The next earnings report will be critical to confirm whether the softness is timing-related or structural.

Thesis delta

The Stoke Space agreement adds operational flexibility but does not change the core thesis: Planet's moat is real but per-share value is constrained by declining firm contracted value and rising capex. The announcement does not address the key near-term issues of Q3 revenue softness or potential ATM dilution, so the wait rating and valuation anchors remain unchanged. It reinforces the view that management is prioritizing capacity expansion, which may sustain growth but also keeps capital discipline in question.